AMLX
Price
$6.50
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
564.26M
39 days until earnings call
DNLI
Price
$14.10
Change
-$0.39 (-2.69%)
Updated
Jun 27 closing price
Capitalization
2.05B
32 days until earnings call
Interact to see
Advertisement

AMLX vs DNLI

Header iconAMLX vs DNLI Comparison
Open Charts AMLX vs DNLIBanner chart's image
Amylyx Pharmaceuticals
Price$6.50
Change-$0.00 (-0.00%)
Volume$1.44K
Capitalization564.26M
Denali Therapeutics
Price$14.10
Change-$0.39 (-2.69%)
Volume$4.08M
Capitalization2.05B
AMLX vs DNLI Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. DNLI commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and DNLI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (AMLX: $6.50 vs. DNLI: $14.10)
Brand notoriety: AMLX and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 0% vs. DNLI: 276%
Market capitalization -- AMLX: $564.26M vs. DNLI: $2.05B
AMLX [@Biotechnology] is valued at $564.26M. DNLI’s [@Biotechnology] market capitalization is $2.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 2 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • DNLI’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than DNLI.

Price Growth

AMLX (@Biotechnology) experienced а +28.84% price change this week, while DNLI (@Biotechnology) price change was +1.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

DNLI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.05B) has a higher market cap than AMLX($564M). AMLX YTD gains are higher at: 71.958 vs. DNLI (-30.815). AMLX has higher annual earnings (EBITDA): -206.81M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. AMLX (204M). AMLX has less debt than DNLI: AMLX (1.38M) vs DNLI (48.6M). DNLI has higher revenues than AMLX: DNLI (0) vs AMLX (-1.27M).
AMLXDNLIAMLX / DNLI
Capitalization564M2.05B28%
EBITDA-206.81M-505.16M41%
Gain YTD71.958-30.815-234%
P/E Ratio2.81N/A-
Revenue-1.27M0-
Total Cash204M818M25%
Total Debt1.38M48.6M3%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXDNLI
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 20 days ago
76%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TBWCX19.970.21
+1.06%
Thornburg Better World International C
AFCSX18.930.19
+1.01%
American Century Focused Intl Gr I
FGIQX16.020.06
+0.38%
Macquarie Growth and Income R6
MSHPX15.22N/A
N/A
Morgan Stanley Inst Permanence R6
VGENX48.24-0.05
-0.10%
Vanguard Energy Inv

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with GRI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
N/A
GRI - AMLX
57%
Loosely correlated
-0.78%
SLRX - AMLX
54%
Loosely correlated
-0.01%
RGNX - AMLX
45%
Loosely correlated
-4.11%
DNLI - AMLX
45%
Loosely correlated
-2.69%
OCUL - AMLX
44%
Loosely correlated
-2.54%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-2.69%
BEAM - DNLI
61%
Loosely correlated
-1.98%
NRIX - DNLI
59%
Loosely correlated
+0.17%
RGNX - DNLI
58%
Loosely correlated
-4.11%
ARWR - DNLI
57%
Loosely correlated
+0.06%
ATXS - DNLI
57%
Loosely correlated
N/A
More